Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.2 USD | 0.00% | -6.29% | +4.06% |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 23-01-18 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 18-10-31 |
Alicia Tozier
SAM | Sales & Marketing | - | 22-03-01 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 22-02-07 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 19-04-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 18-04-12 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 15-12-10 |
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 17-10-30 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20-04-19 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20-04-19 |
Julia Haller
BRD | Director/Board Member | 69 | 22-08-10 |
Director/Board Member | 39 | 17-09-10 | |
Andong Huang
BRD | Director/Board Member | 27 | 20-06-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,542 | 13,636,212 ( 61.15 %) | 0 | 61.15 % |
Company contact information
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.06% | 183M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- OTLK Stock
- Company Outlook Therapeutics, Inc.